Using Translatability Assessment to Refine a Patient-Reported Outcome (PRO) Measure During The Development Process
Stakeholders Share Data to Design Better Trials for Neurodegenerative Diseases The Coalition Against Major Diseases is pooling clinical data to build disease and drug models.
Eliminating Tuberculosis and Tuberculosis-HIV Co-Disease in the 21st Century: Key Perspectives, Controversies, Unresolved Issues, and Needs
Opportunities and Challenges for Cost-Efficient Implementation of New Point-of-Care Diagnostics for HIV and Tuberculosis
Renewed Focus on Tuberculosis Holds Promise for New Treatments FDA approved rifampin for the treatment of tuberculosis (TB) in 1971, the same year Intel Corporation invented the first microproc
